BioCentury
ARTICLE | Clinical News

Theratope: BIOM began a Canadian Phase II trial of Theratope in combination with chemotherapy in 20 patients with metastatic colorectal cancer. Theratope, which

February 11, 2002 8:00 AM UTC

Biomira Inc. (TSE:BRA; BIOM), Edmonton, Alberta Product: Theratope Business: Cancer Therapeutic category: Immune stimulation Target: Immune cells Description: Carbohydrate cancer vaccine containi...